NanoscaleAnimalsDoxorubicinZebrafishThyroid CarcinomaAnaplastic
Heparanase-responsive nanomaterial for anaplastic thyroid cancer chemotherapy.
Xiaofen Yi, Xiangyu Jin, Huihui Yan, Tong Xu, Lu Chen, Dingyi Yu, Kai Wang, Ping Huang
Published: 202510.1039/d5nr01794g
Abstract
Anaplastic thyroid cancer (ATC) is aggressive and has a high mortality rate. Doxorubicin (DOX), the first-line chemotherapy drug for ATC, has an insufficient effective concentration and severe cardiac toxicity, limiting its clinical application. Ther…
Preview only. Read the full abstract at the source